Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels.

Qayyum R, Adomaityte J.

Am J Cardiol. 2006 Mar 1;97(5):655-8. Epub 2006 Jan 9.

PMID:
16490432
3.

The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis.

Zhao Y, He X, Huang C, Fu X, Shi X, Wu Y, Han Y, Li N, Wu Y, Heng CK.

Diabetes Res Clin Pract. 2010 Dec;90(3):279-87. doi: 10.1016/j.diabres.2010.09.011.

PMID:
20926154
4.

Reduction of C-reactive protein levels through use of a multivitamin.

Church TS, Earnest CP, Wood KA, Kampert JB.

Am J Med. 2003 Dec 15;115(9):702-7.

PMID:
14693322
5.

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.

Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, Stier U, Forst T.

J Am Coll Cardiol. 2007 Jan 23;49(3):290-7. Epub 2007 Jan 8.

6.

Pioglitazone reduces monocyte activation in type 2 diabetes.

Pitocco D, Giubilato S, Zaccardi F, Di Stasio E, Buffon A, Biasucci LM, Liuzzo G, Crea F, Ghirlanda G.

Acta Diabetol. 2009 Mar;46(1):75-7. doi: 10.1007/s00592-008-0058-3. Epub 2008 Sep 27.

PMID:
18820825
8.

Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.

Hollander P, Yu D, Chou HS.

Arch Intern Med. 2007 Jun 25;167(12):1284-90.

PMID:
17592102
9.
10.

Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.

Lu L, Pu LJ, Xu XW, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Lu AK, Ding FH, Shen J, Chen QJ, Lou S, Fang DH, Shen WF.

Clin Biochem. 2007 Jul;40(11):810-6. Epub 2007 Apr 19.

PMID:
17499233
11.

Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.

Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.

Metabolism. 2006 Apr;55(4):439-44.

PMID:
16546473
12.
14.

Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.

van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH.

Am J Cardiol. 2006 Jun 15;97(12):1697-701. Epub 2006 Apr 21.

PMID:
16765116
15.
17.
18.

Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.

Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, Balbarini A, Barsotti A.

Coron Artery Dis. 2006 Dec;17(8):693-8.

PMID:
17119378
19.
20.

A meta-analysis of the effect of thiazolidinediones on blood pressure.

Qayyum R, Adomaityte J.

J Clin Hypertens (Greenwich). 2006 Jan;8(1):19-28.

Supplemental Content

Support Center